Sign In

Credits Offered

  • Continuing Medical Education (CME): 10.50 AMA PRA Category 1 Credits
  • Maintenance of Certification (MOC): 10.50 MOC points

Accreditation and Designation Statements

Continuing Medical Education (CME)
The American Association for the Study of Liver Diseases (AASLD) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. AASLD designates this live activity for a maximum of 10.50 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

American Board of Internal Medicine Maintenance of Certification (MOC)
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 10.50 MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC points.

Claiming CME Credits

Physicians and other health care professionals seeking AMA PRA Category 1 Credits™ for this live continuing medical education activity must complete an evaluation by Friday, March 1, 2019. A link to the CME evaluation will be emailed to attendees after the meeting.

Claiming MOC Points

Physicians seeking ABIM MOC points must complete the CME evaluation by March 1, 2019 and participate in the MOC evaluation during the live meeting. The MOC evaluation is included in the online CME evaluation that will be emailed to attendees and will remain live until the deadline.

MOC points will be reported to the ABIM by the end of March 2019 for attendees who successfully complete the MOC evaluation.

Needs Statement

The goal of the conference is to promote global elimination of hepatitis C infection. World leaders in the related disciplines will assemble to establish the current state of the science and public health challenges. The experts will then formulate the most effective future steps toward elimination.

Learning Objectives

Upon completion of this activity, learners will be able to:

  • Describe the major obstacles to global elimination of HCV infection;
  • Identify measures that are likely to reduce the burden of disease;
  • Compare the historic successes to the future needs.

Target Audience

  • Hepatologists
  • Gastroenterologists
  • Infectious Diseases Physicians
  • Public Health Workers

This activity was planned in the context of the following ACGME / IOM / IPEC competencies: Medical Knowledge; Work in Interdisciplinary Teams; Apply Quality Improvement; Values/Ethics for Interpersonal Practice; Roles/Responsibilities; and Teams and Teamwork.